维普中文期刊产品整合服务
81篇 您的检索式:作者名="Nukiwa"
    题名 作者 年代 出处 被引量
1Double-blind,placebocontrolled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,9:1
2Soluble interleukin-2 receptor in lung cancer an indirect marker of tumor activity显示文摘Takahashi S Setoguchi Y Nukiwa T 1991Chest1991,99,6:1
3Double - blind, placebo controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,9:1
4Secretory leukocyte peptidase inhibitor and lung cancer显示文摘Nukiwa T Suzuki T Fukuhara T 2008Cancer Sci2008,99,5:1
5Double blind,placebo controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,9:1
6Double-blind, placebo- controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E ct al 2005Ameriean Journal of Respiratory and Critical Care Medicine2005,,:1
7Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes显示文摘Garver PJ Momex JF Nukiwa T 1986N Engl J Med1986,314,:1
8Double blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis 显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,9:1
9Double-blind, placebo- controlled trial of pirfenidone in patients with idiopathic pul- monary fibrosis 显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,:1
10Carcinoembryonic antigen in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis显示文摘Takahashi H Nukiwa T Matsuoka R 0,,:1
11Double-blind, placebo- controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,9:1
12Double-blind,placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,9:1
13Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601显示文摘Shunichi Sugawara Makoto Maemondo Motoko Tachihara Akira Inoue Osamu Ishimoto Tomohiro Sakakibara Kazuhiro Usui Hiroshi Watanabe Nobumichi Matsubara Kana Watanabe Kenya Kanazawa Takashi Ishida Yasuo Saijo Toshihiro Nukiwa 2013Lung Cancer2013,,1:1
14Double - blind, Placebo controlled Trial of Pirfenidone in Patients with Idiopathic Pulmo- nary Fibrosis 显示文摘Azuma A Nukiwa T Tsuboi E 2005American journal of respiratory and critical care medicine2005,171,9:1
15Double-blind,placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E 0,,:1
16Double-blind,placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,9:1
17Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601显示文摘Shunichi Sugawara Makoto Maemondo Motoko Tachihara Akira Inoue Osamu Ishimoto Tomohiro Sakakibara Kazuhiro Usui Hiroshi Watanabe Nobumichi Matsubara Kana Watanabe Kenya Kanazawa Takashi Ishida Yasuo Saijo Toshihiro Nukiwa 2013Lung Cancer2013,,1:1
18Double-blind, placebo-con- trolled trial of pirfenidone in patients with idiopathic pulmonary fi- brosis显示文摘Azuma A Nukiwa T Tsuboi E 2005Am J Respir Crit Care Med2005,171,:1
19Molecular basis ofα-1-antitrypsin deficiency显示文摘Brantly M Nukiwa T Crystal RG 1988Am J Med1988,84,6:1
20The role of biomarkers in management of inter- stitial lung disease: implication of biomarkers derived from type II pneumocytes 显示文摘Nukiwa T 2009Eur Respir Mon2009,46,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费